HomeCompareGIPIF vs MRK

GIPIF vs MRK: Dividend Comparison 2026

GIPIF yields 88.89% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GIPIF wins by $2.39M in total portfolio value
10 years
GIPIF
GIPIF
● Live price
88.89%
Share price
$2.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.45M
Annual income
$761,533.84
Full GIPIF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GIPIF vs MRK

📍 GIPIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGIPIFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GIPIF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GIPIF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GIPIF
Annual income on $10K today (after 15% tax)
$7,555.56/yr
After 10yr DRIP, annual income (after tax)
$647,303.76/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GIPIF beats the other by $638,975.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GIPIF + MRK for your $10,000?

GIPIF: 50%MRK: 50%
100% MRK50/50100% GIPIF
Portfolio after 10yr
$1.25M
Annual income
$385,665.99/yr
Blended yield
30.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GIPIF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.4
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GIPIF buys
0
MRK buys
0
No recent congressional trades found for GIPIF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGIPIFMRK
Forward yield88.89%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$2.45M$56.8K
Annual income after 10y$761,533.84$9,798.13
Total dividends collected$2.16M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: GIPIF vs MRK ($10,000, DRIP)

YearGIPIF PortfolioGIPIF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$19,589$8,888.89$11,206$366.19+$8.4KGIPIF
2$37,233$16,273.22$12,650$502.35+$24.6KGIPIF
3$68,747$28,907.59$14,407$694.19+$54.3KGIPIF
4$123,442$49,882.87$16,585$967.82+$106.9KGIPIF
5$215,793$83,709.90$19,342$1,363.89+$196.5KGIPIF
6$367,661$136,762.35$22,913$1,947.19+$344.7KGIPIF
7$611,165$217,767.27$27,662$2,823.89+$583.5KGIPIF
8$992,260$338,313.49$34,159$4,173.35+$958.1KGIPIF
9$1,575,055$513,337.08$43,337$6,308.80+$1.53MGIPIF
10$2,446,843$761,533.84$56,776$9,798.13+$2.39MGIPIF

GIPIF vs MRK: Complete Analysis 2026

GIPIFStock

Green Impact Partners Inc., a clean energy company, provides water, waste, and solids treatment and recycling services in North America. It operates through two segments, Water and Industrial, and Energy Production. The company operates seven water and solids treatment and recycling facilities. It also acquires, develops, builds, and operates renewable natural gas (RNG) projects; and distributes RNG, biofuel, and hydrogen. It serves customers in agriculture, forestry, government, midstream, public infrastructure, oil and gas production, potash, and utilities sectors. Green Impact Partners Inc. is based in Vancouver, Canada.

Full GIPIF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GIPIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GIPIF vs SCHDGIPIF vs JEPIGIPIF vs OGIPIF vs KOGIPIF vs MAINGIPIF vs JNJGIPIF vs ABBVGIPIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.